We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$928M
AUM Growth
-$58.7M
Cap. Flow
-$78.8M
Cap. Flow %
-8.49%
Top 10 Hldgs %
24.59%
Holding
191
New
35
Increased
36
Reduced
51
Closed
27

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$15.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$11.9M
3
TSM icon
TSMC
TSM
+$11.7M
4
WYNN icon
Wynn Resorts
WYNN
+$10.1M
5
NOC icon
Northrop Grumman
NOC
+$9.17M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$17.9M
2
STWD icon
Starwood Property Trust
STWD
+$13.1M
3
HDB icon
HDFC Bank
HDB
+$13.1M
4
IBN icon
ICICI Bank
IBN
+$12.9M
5
TXN icon
Texas Instruments
TXN
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 23.46%
2 Technology 13.61%
3 Industrials 12.55%
4 Miscellaneous 11.5%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$130B
$11.5M 1.24%
36,521
-10,690
-23% -$3.21M
WYNN icon
27
Wynn Resorts
WYNN
$8.93B
$10.9M 1.17%
+96,990
New +$10.1M
BRK.A icon
28
Berkshire Hathaway Class A
BRK.A
$1.1T
$10.7M 1.15%
23
-1
-4% -$467K
MRK icon
29
Merck
MRK
$355B
$10.5M 1.13%
98,850
+49,460
+100% +$5.34M
PG icon
30
Procter & Gamble
PG
$341B
$9.74M 1.05%
65,500
– –
LEGN icon
31
Legend Biotech
LEGN
$3.44B
$9.7M 1.05%
201,236
+162,760
+423% +$7.96M
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$15.6B
$9.43M 1.02%
64,410
-20,420
-24% -$3.02M
THC icon
33
Tenet Healthcare
THC
$21B
$9.22M 0.99%
155,225
+6,235
+4% +$347K
BAC icon
34
Bank of America
BAC
$416B
$9.06M 0.98%
316,740
-80,260
-20% -$2.65M
TSLA icon
35
Tesla
TSLA
$1.41T
$8.42M 0.91%
40,594
-18,850
-32% -$3.29M
MCHI icon
36
iShares MSCI China ETF
MCHI
$6.1B
$8.35M 0.9%
+167,400
New +$8.52M
JPM icon
37
JPMorgan Chase
JPM
$937B
$8.14M 0.88%
62,500
– –
ACP
38
abrdn Income Credit Strategies Fund
ACP
$577M
$7.99M 0.86%
+1,197,397
New +$8.92M
PANW icon
39
Palo Alto Networks
PANW
$307B
$7.97M 0.86%
79,790
-100,900
-56% -$8.55M
BSX icon
40
Boston Scientific
BSX
$63.6B
$7.87M 0.85%
157,377
-199,850
-56% -$9.42M
ZTR
41
Virtus Total Return Fund
ZTR
$312M
$7.8M 0.84%
1,205,117
+288,880
+32% +$1.9M
KIO
42
KKR Income Opportunities Fund
KIO
$439M
$7.8M 0.84%
+710,115
New +$8.01M
SEM
43
DELISTED
Select Medical
SEM
$7.69M 0.83%
+552,160
New +$8.13M
VCYT icon
44
Veracyte
VCYT
$3.23B
$7.58M 0.82%
339,978
+23,002
+7% +$556K
BCAT icon
45
BlackRock Capital Allocation Term Trust
BCAT
$1.5B
$7.3M 0.79%
482,030
+73,330
+18% +$1.09M
ZBH icon
46
Zimmer Biomet
ZBH
$18.8B
$7.27M 0.78%
56,270
-44,530
-44% -$5.59M
CSCO icon
47
Cisco
CSCO
$434B
$7.23M 0.78%
138,400
+96,200
+228% +$4.7M
RIG icon
48
Transocean
RIG
$6.63B
$6.76M 0.73%
+1,062,843
New +$6.82M
QCOM icon
49
Qualcomm
QCOM
$201B
$6.7M 0.72%
52,500
+15,400
+42% +$1.91M
PFE icon
50
Pfizer
PFE
$157B
$6.22M 0.67%
152,490
+132,890
+678% +$5.74M
1
2
3 4 5

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Clough Capital Partners held 191 positions worth $928M, down 5.9% from $986M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Clough Capital Partners withdrew a net $78.8M in Q1 2023, closing 27 positions and reducing 51 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Clough Capital Partners opened a new position in Illumina worth $16.8M.

  • Clough Capital Partners's largest Q1 2023 buy was Illumina: 74,335 shares worth $16.8M.
  • Clough Capital Partners added most to Johnson & Johnson in Q1 2023, an estimated $11.9M increase.
  • Clough Capital Partners's biggest Q1 2023 reduction was Starwood Property Trust, cutting an estimated $13.1M.
  • Clough Capital Partners fully exited State Street SPDR S&P Biotech ETF in Q1 2023, selling an estimated $17.9M.
  • Clough Capital Partners's ten largest holdings make up 25% of its $928M portfolio in Q1 2023.
  • Clough Capital Partners opened 35 new positions and closed 27 in Q1 2023.
  • Clough Capital Partners's portfolio value fell 5.9% quarter-over-quarter to $928M.

Based on Clough Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.